FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113452945> ?p ?o ?g. }

• W2113452945 endingPage "2776" @default.
• W2113452945 startingPage "2767" @default.
• W2113452945 abstract "Abstract The use of histone deacetylase (HDAC) inhibitors has shown promise for a variety of malignancies. In this investigation, we define the activity of this class of inhibitors in combination with traditional cytotoxic chemotherapy in endometrial cancer cells. Significant reductions in growth were observed in Ark2 and KLE endometrial cancer cells following treatment with paclitaxel, doxorubicin, carboplatin, or the HDAC inhibitor trichostatin A (TSA). However, only combined treatment with TSA/paclitaxel caused synergistic inhibition of cell growth. This combination also resulted in significant changes in cell morphology. Using cell cycle analysis, nuclear staining, and Western blot analysis for poly(ADP-ribose) polymerase and caspase-9 degradation products, TSA/paclitaxel showed the most dramatic activation of the apoptotic cascade. These effects were also observed when the HDAC inhibitors HDAC inhibitor-1 or oxamflatin were substituted for TSA. The anticancer properties of paclitaxel are known to result in part from inhibition of microtubule depolymerization, which results in apoptosis. We show that TSA administration also stabilizes microtubules via α-tubulin acetylation. Furthermore, using Western blot and immunohistochemical analysis, treatment with TSA/paclitaxel led to a significant increase in acetylated tubulin and microtubule stabilization. These effects were confirmed in a mouse xenograft model. Moreover, TSA/paclitaxel resulted in a 50% reduction in tumor weight compared with either agent alone. This study provides in vivo evidence of nonhistone protein acetylation as one possible mechanism by which HDAC inhibitors reduce cancer growth. The TSA/paclitaxel combination seems to hold promise for the treatment of serous endometrial carcinoma and other malignancies with limited sensitivity to paclitaxel. [Mol Cancer Ther 2006;5(11):2767–76]" @default.
• W2113452945 created "2016-06-24" @default.
• W2113452945 creator A5025312613 @default.
• W2113452945 creator A5029073714 @default.
• W2113452945 creator A5037737706 @default.
• W2113452945 creator A5042220379 @default.
• W2113452945 creator A5044139867 @default.
• W2113452945 creator A5052683398 @default.
• W2113452945 creator A5066146057 @default.
• W2113452945 date "2006-11-01" @default.
• W2113452945 modified "2023-10-01" @default.
• W2113452945 title "Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells" @default.
• W2113452945 cites W1504303645 @default.
• W2113452945 cites W1568781574 @default.
• W2113452945 cites W1626483287 @default.
• W2113452945 cites W1906875137 @default.
• W2113452945 cites W1967764533 @default.
• W2113452945 cites W1977374685 @default.
• W2113452945 cites W1979832500 @default.
• W2113452945 cites W2000243200 @default.
• W2113452945 cites W2000816728 @default.
• W2113452945 cites W2004172747 @default.
• W2113452945 cites W2018152463 @default.
• W2113452945 cites W2019731805 @default.
• W2113452945 cites W2024112030 @default.
• W2113452945 cites W2029484950 @default.
• W2113452945 cites W2035172187 @default.
• W2113452945 cites W2038768662 @default.
• W2113452945 cites W2039966201 @default.
• W2113452945 cites W2042490816 @default.
• W2113452945 cites W2073869856 @default.
• W2113452945 cites W2074696167 @default.
• W2113452945 cites W2081406767 @default.
• W2113452945 cites W2087552260 @default.
• W2113452945 cites W2089253083 @default.
• W2113452945 cites W2090039904 @default.
• W2113452945 cites W2115354390 @default.
• W2113452945 cites W2118510249 @default.
• W2113452945 cites W2118925298 @default.
• W2113452945 cites W2133058429 @default.
• W2113452945 cites W2135619784 @default.
• W2113452945 cites W2144977863 @default.
• W2113452945 cites W2163288644 @default.
• W2113452945 doi "https://doi.org/10.1158/1535-7163.mct-06-0209" @default.
• W2113452945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17121923" @default.
• W2113452945 hasPublicationYear "2006" @default.
• W2113452945 type Work @default.
• W2113452945 sameAs 2113452945 @default.
• W2113452945 citedByCount "129" @default.
• W2113452945 countsByYear W21134529452012 @default.
• W2113452945 countsByYear W21134529452013 @default.
• W2113452945 countsByYear W21134529452014 @default.
• W2113452945 countsByYear W21134529452015 @default.
• W2113452945 countsByYear W21134529452016 @default.
• W2113452945 countsByYear W21134529452017 @default.
• W2113452945 countsByYear W21134529452018 @default.
• W2113452945 countsByYear W21134529452019 @default.
• W2113452945 countsByYear W21134529452020 @default.
• W2113452945 countsByYear W21134529452021 @default.
• W2113452945 countsByYear W21134529452022 @default.
• W2113452945 countsByYear W21134529452023 @default.
• W2113452945 crossrefType "journal-article" @default.
• W2113452945 hasAuthorship W2113452945A5025312613 @default.
• W2113452945 hasAuthorship W2113452945A5029073714 @default.
• W2113452945 hasAuthorship W2113452945A5037737706 @default.
• W2113452945 hasAuthorship W2113452945A5042220379 @default.
• W2113452945 hasAuthorship W2113452945A5044139867 @default.
• W2113452945 hasAuthorship W2113452945A5052683398 @default.
• W2113452945 hasAuthorship W2113452945A5066146057 @default.
• W2113452945 hasConcept C104317684 @default.
• W2113452945 hasConcept C119157956 @default.
• W2113452945 hasConcept C121608353 @default.
• W2113452945 hasConcept C126322002 @default.
• W2113452945 hasConcept C185592680 @default.
• W2113452945 hasConcept C2776202225 @default.
• W2113452945 hasConcept C2776694085 @default.
• W2113452945 hasConcept C2777292972 @default.
• W2113452945 hasConcept C2777865847 @default.
• W2113452945 hasConcept C2778239845 @default.
• W2113452945 hasConcept C2778305200 @default.
• W2113452945 hasConcept C2781451048 @default.
• W2113452945 hasConcept C502942594 @default.
• W2113452945 hasConcept C55493867 @default.
• W2113452945 hasConcept C64927066 @default.
• W2113452945 hasConcept C71924100 @default.
• W2113452945 hasConcept C86803240 @default.
• W2113452945 hasConcept C96232424 @default.
• W2113452945 hasConcept C98274493 @default.
• W2113452945 hasConceptScore W2113452945C104317684 @default.
• W2113452945 hasConceptScore W2113452945C119157956 @default.
• W2113452945 hasConceptScore W2113452945C121608353 @default.
• W2113452945 hasConceptScore W2113452945C126322002 @default.
• W2113452945 hasConceptScore W2113452945C185592680 @default.
• W2113452945 hasConceptScore W2113452945C2776202225 @default.
• W2113452945 hasConceptScore W2113452945C2776694085 @default.
• W2113452945 hasConceptScore W2113452945C2777292972 @default.
• W2113452945 hasConceptScore W2113452945C2777865847 @default.
• W2113452945 hasConceptScore W2113452945C2778239845 @default.

• next